CGJIX
Price
$85.15
Change
-$0.26 (-0.30%)
Updated
Aug 14 closing price
Net Assets
1.04B
GAFFX
Price
$89.18
Change
-$0.54 (-0.60%)
Updated
Aug 14 closing price
Net Assets
342.42B
Interact to see
Advertisement

CGJIX vs GAFFX

CGJIX vs GAFFX Comparison Chart in %
View a ticker or compare two or three
VS
CGJIX vs. GAFFX commentary
Aug 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGJIX is a Buy and GAFFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 342B vs. CGJIX (1.04B). GAFFX pays higher dividends than CGJIX: GAFFX (0.53) vs CGJIX (0.41). CGJIX was incepted earlier than GAFFX: CGJIX (11 years) vs GAFFX (10 years). CGJIX (0.39) is less costly to investors than GAFFX (0.29). GAFFX is a more actively managed with annual turnover of: 32.00 vs. CGJIX (30.00). CGJIX (1000000) and GAFFX (1000000) have matching initial minimum investment requirements. CGJIX annual gain was more profitable for investors over the last year : 16.33 vs. GAFFX (5.10). CGJIX return over 5 years is better than : 68.46 vs. GAFFX (19.12).
CGJIXGAFFXCGJIX / GAFFX
Total Expense Ratio0.240.2983%
Annual Report Gross Expense Ratio0.390.29134%
Fund Existence11 years10 years-
Gain YTD13.06610.810121%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B342B0%
Annual Yield % from dividends0.410.5378%
Returns for 1 year16.335.10320%
Returns for 3 years74.5948.81153%
Returns for 5 years68.4619.12358%
Returns for 10 years334.25N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIERX31.350.05
+0.16%
Brandes International Equity R6
MDEGX17.610.02
+0.11%
BlackRock Unconstrained Equity Inv A
FLCOX25.65N/A
N/A
Fidelity Large Cap Value Index
SUSSX17.93-0.03
-0.17%
State Street Instl US Equity Svc
SRFMX12.70-0.04
-0.31%
Sarofim Equity